LAWRENCE S. COHEN, M.D.; ROBERT A. BUCCINO, M.D.; ANDREW G. MORROW, M.D.; EUGENE BRAUNWALD, M.D., F.A.C.P.
Paroxysmal ventricular tachycardia is most often associated with organic heart disease and in this setting is of ominous prognostic import (1-3). Less commonly, this arrhythmia occurs in young individuals without underlying heart disease; in these patients the disorder is generally considered benign (4). However, in some of these patients the episodes of paroxysmal ventricular tachycardia may lead to syncope and sudden death (2, 5). Recently, the efficacy of the beta-adrenergic blocking drugs in the treatment of tachyarrhythmias has been recognized (6, 7), and these drugs have been employed with success in certain patients with recurrent ventricular tachycardia (8-11). Electrical pacemakers
COHEN LS, BUCCINO RA, MORROW AG, et al. Recurrent Ventricular Tachycardia and Fibrillation Treated with a Combination of Beta-Adrenergic Blockade and Electrical Pacing. Ann Intern Med. 1967;66:945–949. doi: https://doi.org/10.7326/0003-4819-66-5-945
Download citation file:
Published: Ann Intern Med. 1967;66(5):945-949.
Cardiology, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use